Call for Papers

USIU-Africa, School of Pharmacy and Health science invites you to submit your abstract for presentation to its first International Pharmaceutical and health sciences research conference and exhibition (IPHRCE 2022).

Theme: Collaborative research for distinction in research and scholarship

Tracks: IPHRCE 2022 is built on four tracks that cover the pharmaceutical and health science research, and Science, technology, engineering and Mathematics (STEM) and innovations.

  1. Drug discovery, development and Clinical Pharmacy
  2. Social and Regulatory pharmacy
  3. Health sciences research
  4. STEM and Innovation

Important dates

  • Conference registration starts-  May 1, 2022
  • Open for abstract submission- May 15, 2022
  • Early registration discount ends- August 31, 2022
  • Abstract submission deadline August 15, 2022
  • Abstract accept/ reject notifications September 05-15, 2022
  • Presenting-author registration deadline- September 30, 2022
  • Schedule notification- October 05, 2022
  • Deadline for submission of full poster or power point slides- October 10, 2022
  • Conference registration ends October 22, 2022

Note: Authors who have had their abstracts accepted are required to register for the conference before -  Friday, September 30, 2022.

 

Refer the Author guidelines below before submitting your abstract

Author Guidelines

Author Guidlines

By submitting an abstract for presentation at IPHRCE, you agree to abide by the conditions and policies provided below, as well as the decisions of the IPHRCE scientific sub-committee. Direct questions about this policy to pharmaconference@usiu.ac.ke.

  1. Abstracts must be submitted through the conference website on or before August 15, 2022. Abstracts submitted after this deadline or by different means will be rejected without review.
  2. For STEM and health care products innovation- A brief of write up of the innovation or the finding should be submitted using the abstract submission link.
  3. Exhibitors should submit the detail of their plan and items of exhibition using the submission link.
  4. Data supporting the conclusion of the abstract must be submitted during abstract submission. Abstracts stating that data will be developed between the time of submission and the time of the meeting will be rejected without review.
  5. Permissions/clearances- It is the responsibility of the author(s) to obtain the necessary ethical clearance and approval for all research before submitting an abstract. The School of Pharmacy and Health Sciences and IPHRCE assume no liability or responsibility for the publication of any material that is submitted. Use of the USIU-AFRICA logo in any abstract submission or poster presentation is STRICTLY PROHIBITED.
  6. Registration requirement for publication and scheduling- The presenting author is required to attend the meeting via face to face (using PowerPoint slides or poster) or online (using PowerPoint slides) to present the research work. If the presenting author is unable to attend the meeting, a co-author is required to assume the responsibilities of the presenting author. The presenting author is required to register for the conference on or before Friday, September 30, 2022. Failure to do so will be considered as withdrawn abstract. Withdrawn abstracts/ posters will not be published online or presented during the meeting.
  7. Notification of receipt and verification of submission. You will receive an immediate email confirmation of completion when you have successfully submitted the abstract. This notification only confirms receipt of your submission and is not a notification of acceptance. If you do not receive an immediate email confirmation, your submission is not complete. You must return to the submission site to complete the submission process. If you return to the submission site to review or make changes to your abstract for any reason, you must complete all submission steps again to be sure your abstract is successfully submitted.
  8. Abstract/poster withdrawal- The submitting author may withdraw their abstract or poster at any time. To withdraw, send written notification to pharmaconference@usiu, and include: 1. Submission ID Number (Assigned Number if withdrawing after conference schedule is issued), 2. Abstract title, 3. Names of authors, 4. Contact information for the submitter. IPHRCE will acknowledge all withdrawal notifications by email. Withdrawal is not complete until IPHRCE issues a notification of withdrawal to the submitting author.
  9. Cancellation & refund policies- Conference registrants canceling their registration on or before July 10, 2022 will receive a refund of the conference registration fee, less a $ 100 administrative fee. Note that individuals who register for the in-person option but can no longer attend the in-person proceedings may switch to the virtual registration and receive a refund of the difference in fees, so long as that is also done on or before August 30, 2022.  If you switch registration types, you are subject to the current rate at the time of switching. No adjustments will be provided after August 30. No refunds are available after August 30, 2022. All cancellation requests and questions must be emailed to pharmaconference@usiu.ac.ke
  10. Posters or PowerPoint slides must include the accepted abstract. Posters or PowerPoint slides that are uploaded for presentation must include the accepted abstract, including all methods used and data resulting from the research. The title of the poster or PowerPoint slides must match, verbatim, the title of the accepted abstract. Omitting data from a poster or PowerPoint slide presentation that was included in the submitted abstract is unethical. Authors and organizations violating these requirements will be subject to penalties including withdrawal of their paper and being barred from submitting to any future IPHRCE conferences.
  11. Abstract blinding and review- All submitted abstracts will go through a blind peer-review process carried out by an independent reviewing scientific subcommittee. The committee will post reviewer’s comments to the corresponding authors through emails.
  12. Acceptance criteria- Acceptance of the abstract for presentation will be based on the concise, accurate presentation of new data. It is imperative that data is presented in the results section so that IPHRCE scientific subcommittee can judge the scientific value of your abstract. Include all research information, data, charts, and graphs in your submission so that it can be screened in its entirety. Abstracts will be reviewed and scored based on the following:
  • Is the CONCLUSION of the research data driven?
  • How EXCITING/NOVEL will viewers find this research?
  • How well does the RESEARCH incrementally advance its field?
  • How well does the author’s selected strategy for evaluating the HYPOTHESIS suit the project?

13. Rejection criteria-The IPHRCE Scientific sub-committee reviews each abstract to ensure it is qualified for consideration. Abstracts that do not meet the requirements outlined above are rejected. Causes for rejection include:

  • Lack of data.
  • Commerciality.
  • Inconsistent or ambiguous data.
  • Reviews of literature.
  • Lack of novelty or innovation.
  • Stating that data or information will be included in the poster presentation instead of including it in the abstract.
  • Failure to follow format guidelines (Background, Objective, Methods, Results, Conclusions, Key words, Acknowledgements).
  • Failure to upload tables or charts as images as directed (tables and/or charts are not to be included in the text box for the Purpose, Methods, Results, or Conclusions. Tables and/or charts must be uploaded as images).
  • Failure to submit one strong abstract instead of several abstracts presenting the same work. The submission of multiple abstracts covering the same or similar work is discouraged and may be rejected by the committee.

14. Notification of acceptance or rejection-Notification of acceptance or rejection will be sent to the corresponding author. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of their abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

15. Abstract revisions- Once requested to revise your abstract, submit revised version of your abstract within 10 working days. Revisions cannot be made after October 10, 2022. Author names and affiliation or company names will be published as submitted. Be sure you have the correct and current author information. Proofread, spell-check, and make sure all authors are listed on your abstract before submitting. Abstracts will be presented in conference materials exactly as they appear at the time of submission.

16. Publication of the Conference proceedings: All the accepted abstracts will be published as E-Book of abstracts/ conference proceeding. If you have any questions regarding your abstract submission, please contact the abstract support team at pharmaconference@usiu.ac.ke



Start here to submit a paper to this conference.
Step one of the submission process



Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

For further detail, feel free to contact us pharmaconference@usiu.ac.ke